The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Atrial Fibrillation in the ICU
Open accessAbstract
Atrial fibrillation (AF) is the most common arrhythmia encountered in the ICU. Preexisting AF is highly prevalent among older patients with chronic conditions who are at risk for critical illness, whereas new-onset AF can be triggered by accelerated atrial remodeling and arrhythmogenic triggers encountered during critical illness. The acute loss of atrial systole and onset of rapid ventricular rates that characterize new-onset AF often lead to decreased cardiac output and hemodynamic compromise. Thus, new-onset AF is both a marker of disease severity as well as a likely contributor to poor outcomes, similar to other manifestations of organ dysfunction during critical illness. Evaluating immediate hemodynamic effects of new-onset AF during critical illness is an important component of rapid clinical assessment aimed at identifying patients in need of urgent direct current cardioversion, treatment of reversible inciting factors, and identification of patients who may benefit from pharmacologic rate or rhythm control. In addition to acute hemodynamic effects, new-onset AF during critical illness is associated with both short- and long-term increases in the risk of stroke, heart failure, and death, with AF recurrence rates of approximately 50% within 1 year following hospital discharge. In the absence of a strong evidence base, there is substantial practice variation in the choice of strategies for management of new-onset AF during critical illness. We describe acute and long-term evaluation and management strategies based on current evidence and propose future avenues of investigation to fill large knowledge gaps in the management of patients with AF during critical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats
Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,494
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Epidemiologic Features of Chronic Atrial Fibrillation: The Framingham Study
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,314
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000140263.20897.42 · Cited by 2,041
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation
Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1180 · Cited by 1,401
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273
Santhanakrishnan, R., Wang, N., Larson, M. G., Magnani, J. W., McManus, D. D., Lubitz, S. A., Ellinor, P. T., Cheng, S., Vasan, R. S., Lee, D. S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018614 · Cited by 870
Ionic Remodeling Underlying Action Potential Changes in a Canine Model of Atrial Fibrillation
Yue, L., Feng, J., Gaspo, R., Li, G.-R., Wang, Z., & Nattel, S. (1997) · Circulation Research · doi:10.1161/01.res.81.4.512 · Cited by 813
Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
Rathore, S. S., Curtis, J. P., Wang, Y., Bristow, M. R., & Krumholz, H. M. (2003) · JAMA · doi:10.1001/jama.289.7.871 · Cited by 772
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D’Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 720
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation
Mihm, M. J., Yu, F., Carnes, C. A., Reiser, P. J., McCarthy, P. M., Van Wagoner, D. R., & Bauer, J. A. (2001) · Circulation · doi:10.1161/01.cir.104.2.174 · Cited by 667
Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation
Clark, D. M., Plumb, V. J., Epstein, A. E., & Kay, G. N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00254-4 · Cited by 609
Fúster, & Westerling, R. (2001) · Circulation · Cited by 607
Committee Members, Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 604
Walkey, A. J., Wiener, R. S., Ghobrial, J. M., Curtis, L. H., & Benjamin, E. J. (2011) · JAMA · doi:10.1001/jama.2011.1615 · Cited by 487
Self-citationDiastolic dysfunction and mortality in severe sepsis and septic shock
Landesberg, G., Gilon, D., Meroz, Y., Georgieva, M., Levin, P. D., Goodman, S., Avidan, A., Beeri, R., Weissman, C., Jaffe, A. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr351 · Cited by 472
Frendl, G., Sodickson, A. C., Chung, M. K., Waldo, A. L., Gersh, B. J., Tisdale, J. E., Calkins, H., Aranki, S., Kaneko, T., Cassivi, S., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.036 · Cited by 343
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Zimetbaum, P. (2012) · Circulation · doi:10.1161/circulationaha.111.019927 · Cited by 277
Klein Klouwenberg, P. M. C., Frencken, J. F., Kuipers, S., Ong, D. S. Y., Peelen, L. M., van Vught, L. A., Schultz, M. J., van der Poll, T., Bonten, M. J., & Cremer, O. L. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0618oc · Cited by 261
Long-term Outcomes Following Development of New-Onset Atrial Fibrillation During Sepsis
Walkey, A. J., Hammill, B. G., Curtis, L. H., & Benjamin, E. J. (2014) · Chest · doi:10.1378/chest.14-0003 · Cited by 256
Self-citationMeierhenrich, R., Steinhilber, E., Eggermann, C., Weiss, M., Voglic, S., Bögelein, D., Gauss, A., Georgieff, M., & Stahl, W. (2010) · Critical Care · doi:10.1186/cc9057 · Cited by 251
Clemo, H. F., Wood, M. A., Gilligan, D. M., & Ellenbogen, K. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00962-4 · Cited by 215
Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
Platia, E. V., Michelson, E. L., Porterfield, J. K., & Das, G. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90141-0 · Cited by 213
Khan, A. M., Lubitz, S. A., Sullivan, L. M., Sun, J. X., Levy, D., Vasan, R. S., Magnani, J. W., Ellinor, P. T., Benjamin, E. J., & Wang, T. J. (2013) · Circulation · doi:10.1161/circulationaha.111.082511 · Cited by 206
Brown, A. O., Mann, B., Gao, G., Hankins, J. S., Humann, J., Giardina, J., Faverio, P., Restrepo, M. I., Halade, G. V., Mortensen, E. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004383 · Cited by 195
Resnekov, L., & McDonald, L. (1967) · Heart · doi:10.1136/hrt.29.6.926 · Cited by 194
Hou, Z.-Y., CHANG, M.-S., CHEN, C.-Y., TU, M.-S., LIN, S.-L., CHIANG, H.-T., & WOOSLEY, R. L. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060945 · Cited by 178
Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias
Delle Karth, G., Geppert, A., Neunteufl, T., Priglinger, U., Haumer, M., Gschwandtner, M., Siostrzonek, P., & Heinz, G. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00011 · Cited by 173
New-Onset Atrial Fibrillation in the Critically Ill*
Moss, T. J., Calland, J. F., Enfield, K. B., Gomez-Manjarres, D. C., Ruminski, C., DiMarco, J. P., Lake, D. E., & Moorman, J. R. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002325 · Cited by 172
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients*
Shaver, C. M., Chen, W., Janz, D. R., May, A. K., Darbar, D., Bernard, G. R., Bastarache, J. A., & Ware, L. B. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001166 · Cited by 160
Serum potassium levels and the risk of atrial fibrillation
Krijthe, B. P., Heeringa, J., Kors, J. A., Albert Hofman, D., Franco, O. H., Witteman, J. C. M., & Stricker, B. H. C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.048 · Cited by 159
Kanji, S., Williamson, D. R., Yaghchi, B. M., Albert, M., & McIntyre, L. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.10.011 · Cited by 158
Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone*
Ott, M. C., Khoór, A., Leventhal, J. P., Paterick, T. E., & Burger, C. D. (2003) · CHEST Journal · doi:10.1378/chest.123.2.646 · Cited by 156
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling
Reyes, L. F., Restrepo, M. I., Hinojosa, C. A., Soni, N. J., Anzueto, A., Babu, B. L., González-Juarbe, N., Rodríguez, A. H., Jiménez, A., Chalmers, J. D., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0104oc · Cited by 148
Walkey, A. J., Greiner, M. A., Heckbert, S. R., Jensen, P. N., Piccini, J. P., Sinner, M. F., Curtis, L. H., & Benjamin, E. J. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.020 · Cited by 146
Self-citationMorelli, A., Singer, M., Ranieri, V. M., D’Egidio, A., Mascia, L., Orecchioni, A., Piscioneri, F., Guarracino, F., Greco, E., Peruzzi, M., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4351-2 · Cited by 129
New insights into mechanisms of atrial fibrillation
Aldhoon, B., Melenovský, V., Peichl, P., & Kautzner, J. (2010) · Physiological Research · doi:10.33549/physiolres.931651 · Cited by 126
Atrial fibrillation in trauma patients requiring intensive care
Séguin, P., Laviolle, B., Maurice, A., Leclercq, C., & Mallédant, Y. (2006) · Intensive Care Medicine · doi:10.1007/s00134-005-0032-2 · Cited by 111
Inflammation in new‐onset atrial fibrillation after cardiac surgery: a systematic review
Jacob, K. A., Nathoe, H. M., Dieleman, J. M., van Osch, D., Kluin, J., & van Dijk, D. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12237 · Cited by 107
Walkey, A. J., Quinn, E. K., Winter, M. R., McManus, D. D., & Benjamin, E. J. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2181 · Cited by 99
Self-citationAbrams, J., Allen, J., Allin, D., Anderson, J. L., Anderson, S., Blanski, L., Chadda, K., DiBianco, R., Favrot, L. K., Gonzalez, J., et al. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90185-1 · Cited by 97
Siu, C.-W., Lau, C.-P., Lee, W.-L., Lam, K.-F., & Tse, H.-F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02f56 · Cited by 96
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Ho, K. M., Sheridan, D., & Paterson, T. (2007) · Heart · doi:10.1136/hrt.2006.111492 · Cited by 89
Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis
Walkey, A. J., Evans, S. R., Winter, M. R., & Benjamin, E. J. (2015) · CHEST Journal · doi:10.1378/chest.15-0959 · Cited by 88
Self-citationDavey, M. J., & Teubner, D. J. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.09.013 · Cited by 74
Chen, A. Y., Sokol, S. S., Kress, J. P., & Lat, I. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015574726 · Cited by 63
Optimizing Atrial Fibrillation Management
Walkey, A. J., Hogarth, D. K., & Lip, G. Y. H. (2015) · CHEST Journal · doi:10.1378/chest.15-0358 · Cited by 60
Self-citationThyroid hormone regulates mRNA expression and currents of ion channels in rat atrium
Watanabe, H., Ma, M., Washizuka, T., Komura, S., Yoshida, T., Hosaka, Y., Hatada, K., Chinushi, M., Yamamoto, T., Watanabe, K., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01420-7 · Cited by 59
Lu, Y., Cheng, C., Chen, Y., Lin, Y., Chen, S.-A., & Chen, Y.-J. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.005 · Cited by 54
Eisen, A., Ruff, C. T., Braunwald, E., Hamershock, R. A., Lewis, B. S., Hassager, C., Chao, T., Heuzey, J. Y. L., Mercuri, M. F., Rutman, H., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006035 · Cited by 48
Moskowitz, A. L., Chen, K. P., Cooper, A. Z., Chahin, A. B., Ghassemi, M. M., & Celi, L. A. (2017) · Shock · doi:10.1097/shk.0000000000000869 · Cited by 45
Amsterdam, E. A., Kulcyski, J., & Ridgeway, M. G. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03765.x · Cited by 42
Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
Ang, E. L., Chan, W. L., Cleland, J. G. F., Moore, D., Krikler, S. J., Alexander, N. D. E., & Oakley, C. M. (1990) · Heart · doi:10.1136/hrt.64.4.256 · Cited by 40
Launey, Y., Lasocki, S., Asehnoune, K., Gaudriot, B., Chassier, C., Cinotti, R., Maguet, P. L., Laksiri, L., Mimoz, O., Tawa, A., et al. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617696847 · Cited by 33
New-onset supraventricular arrhythmia during septic shock: prevalence, risk factors and prognosis
Seemann, A., Boissier, F., Razazi, K., Carteaux, G., de Prost, N., Brun‐Buisson, C., & Dessap, A. M. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0069-5 · Cited by 30
Intravenous amiodarone for cardioversion of recent‐onset atrial fibrillation
Cybulski, J., Kułakowski, P., Budaj, A., Danielewicz, H., Maciejewicz, J., Kawka‐Urbanek, T., & Ceremuzyński, L. (2003) · Clinical Cardiology · doi:10.1002/clc.4950260707 · Cited by 22
When Rhythm Changes Cause the Blues: New-Onset Atrial Fibrillation during Sepsis
Walkey, A. J., & McManus, D. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201608-1617ed · Cited by 18
Self-citationNon-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation
Vieillard‐Baron, A., & Boyd, J. H. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4986-7 · Cited by 17
Brown, A. O., & Orihuela, C. J. (2015) · Journal of Visualized Experiments · doi:10.3791/52590-v · Cited by 14
Metadata
- Authors
- Bosch, N. A., Cimini, J., & Walkey, A. J.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 154
- Issue
- 6
- Pages
- 1424-1434
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2796310473
- Cited by
- 301
- References
- 65
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.